Intratio
Quantitative Research
Skip to main content
AI Market Summary
Loading market intelligence...
  • Sign in
    My account
    Logout
AI 90-DAY FORECAST
NEUTRAL SIGNAL
██.█% Sign up free to reveal

Clene Inc. (CLNN) AI Forecast

Our AI analyzed Clene Inc.. Create a free account to see the 90-day price prediction.

✓ Free account • ✓ 30-day free trial

$CLNN Neutral Signal Full forecast available
Sign Up Free

Clene Inc. (CLNN) Stock Forecast 2025

Clene Inc. (CLNN) AI Stock Price Forecast & Investment Analysis

Clene Inc. Stock Price Chart and Technical Analysis

Loading chart...

Clene Inc. (CLNN) - Comprehensive Stock Analysis & Investment Research

Deep dive into Clene Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Analysis updated on May 27, 2026, 5:46 p.m. (UTC)

Clene Inc. Investment Summary

When evaluating whether Clene Inc. (CLNN) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.

Company Profile

Clene Inc. (CLNN) operates within the Life Sciences sector, specifically in the Pharmaceutical Preparations industry. . With a market capitalization of $77 million, the company is a small-cap stock that may offer higher growth potential but also carries higher volatility.

Financial Performance Analysis

Our comprehensive financial analysis covers Clene Inc.'s revenue, profitability metrics, balance sheet strength, and cash flow generation...

AI Price Predictions

Get AI-powered 7-day, 30-day and 90-day price forecasts for Clene Inc. along with confidence scores and detailed analysis...

Investment Considerations

Expert analysis of whether Clene Inc. is suitable for your investment objectives, risk tolerance, and time horizon...

Continue Reading Full Analysis

Get the complete investment breakdown for Clene Inc.

Sign Up Free
Corporate Identity

Clene Inc. (Stock Symbol: CLNN) is a prominent company operating within the Life Sciences sector, with a specific focus on the Pharmaceutical Preparations industry. The company's shares are publicly traded on the Nasdaq exchange.

Leadership & Workforce

Detailed information about Clene Inc.'s leadership team, workforce size, and organizational structure...

Market Classification

Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Clene Inc....

Sector & Industry Analysis

In-depth sector dynamics and industry context for Clene Inc....

Unlock Full Company Profile

Get complete details about Clene Inc.

Sign Up Free
Revenue & Growth Analysis
Profitability Metrics

Net profit margin, gross margin, and operating margin analysis for Clene Inc....

Market Valuation

P/E ratio, price-to-book, and valuation multiples for Clene Inc....

Return Metrics

Return on equity (ROE), return on assets (ROA), and capital efficiency for Clene Inc....

Unlock Financial Analysis

Get complete financial metrics for Clene Inc.

Sign Up Free
AI ANALYSIS AVAILABLE

Unlock Clene Inc.'s AI Price Forecast

Join 10,000+ investors using our 67%+ accurate AI predictions

4,000+ Stocks Analyzed
67%+ Accuracy Rate
Daily Updates
Start 30-Day Free Trial →

✓ 30-day free trial • ✓ Cancel anytime

Strategic Market Position

Clene Inc. strategically competes in the highly dynamic Pharmaceutical Preparations marketplace. As a small-cap company, it represents an emerging market participant with potentially significant growth opportunities. Small-caps often offer greater growth potential as they capture market share and scale their operations, though this comes with higher risk and volatility. Success at this stage can lead to substantial returns for early investors who identify winning business models.

Industry Competitive Landscape

Clene Inc. competes within the Life Sciences sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.

Operational Efficiency

The company currently shows negative free cash flow of $-18 million . Negative free cash flow may reflect heavy investment in growth, working capital needs, or operational challenges. This is common for high-growth companies investing aggressively but warrants attention for mature businesses.

Asset Utilization Efficiency

Asset turnover ratio of 0.01x indicates lower asset turnover that may reflect the industry's capital-intensive nature or potentially underutilized assets. Companies with low turnover typically depend on strong margins to generate adequate returns on capital.

Financial Strength & Leverage

Current ratio of 1.94 indicates adequate liquidity to meet short-term obligations with reasonable cushion. This level balances working capital efficiency with financial safety.

Clene Inc. (CLNN) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Clene Inc. stock analysis.

Deep dive into Clene Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Clene Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Clene Inc.:

Market Cap $77M
Revenue/Share $0.01
FCF/Share $-1.54
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Clene Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Clene Inc.: An ROE of 102.5% demonstrates excellent shareholder value creation.

ROE 102.5%
ROA -89.0%
ROIC -135.4%
Operating Margin -9812.6%
Net Margin -9357.8%
EBT Margin -9160.7%
Tax Rate -2.2%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Clene Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Clene Inc.: A current ratio of 1.94 shows adequate liquidity.

Current Ratio 1.94x
Quick Ratio 1.93x
D/E Ratio -2.15x
Financial Leverage -1.15x
Interest Coverage -2.6x
Working Capital $6M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Clene Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Clene Inc.: Free cash flow of $-18M indicates cash challenges that need attention.

Operating Cash Flow -$19M
Free Cash Flow -$18M
Capital Spending $830K
FCF/Sales -13506.5%
CapEx/Sales 619.7%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Clene Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Clene Inc.: An asset turnover of 0.01x suggests room for improvement in asset utilization.

Asset Turnover 0.01x
Fixed Assets Turnover 0.0x
Understanding Financial Statement Data

What these metrics mean: Key figures from Clene Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Clene Inc.:

Income Statement
Operating Income -$20M
Net Income -$19M
R&D Expense $15M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 13%
Cash & Short-term Investments 6%
Total Liabilities 40%
Short-term Debt 5%
Inventory 0%
Dividend & Shareholder Information
Shares Outstanding 12M
Growth Metrics (YoY)
Net Income Growth -9357.8%

Latest Clene Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Clene Inc. (CLNN) stock price and investment outlook.

More news available

Sign up free to read all 9 news articles and stay updated on market developments.

Sign Up Free to Read More

Clene Inc. Competitors & Peer Analysis - Life Sciences Sector

Comparative analysis of Clene Inc. against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
Aardvark Therapeutics, Inc. AARD ██% $92M x 1.1x
Abbvie Inc. ABBV ██% $377.15B 103.8x x
Abcellera Biologics Inc. ABCL ██% $1.61B x 1.7x
Abeona Therapeutics Inc. ABEO ██% $325M 4.9x 2.2x
Abbott Laboratories ABT ██% $150.96B 24.1x 2.9x
Arbutus Biopharma Corp ABUS ██% $914M 5.7x 3.5x
Abvc Biopharma, Inc. ABVC ██% $35M x 3.2x
Abivax S.A. ABVX ██% $9.93B x x
Acadia Pharmaceuticals Inc ACAD ██% $3.63B 9.7x 2.9x
Adicet Bio, Inc. ACET ██% $78M x 0.6x
Aclaris Therapeutics, Inc. ACRS ██% $630M x 4.4x
Acrivon Therapeutics, Inc. ACRV ██% $65M x 0.7x
Actuate Therapeutics, Inc. ACTU ██% $120M x 11.0x
Accustem Sciences Inc. ACUT ██% $4M x x
Acurx Pharmaceuticals, Inc. ACXP ██% $8M x 1.2x
Adagene Inc. ADAG ██% $251M x 6.6x
Adc Therapeutics Sa ADCT ██% $447M x x
Adial Pharmaceuticals, Inc. ADIL ██% $5M x 1.3x
Aditxt, Inc. ADTX ██% $130K x x
Addex Therapeutics Ltd. ADXN ██% $8M x x
Aeon Biopharma, Inc. AEON ██% $19M x x
Agios Pharmaceuticals, Inc. AGIO ██% $1.68B x 1.5x
Akebia Therapeutics, Inc. AKBA ██% $279M x 10.2x
Akero Therapeutics, Inc. AKRO ██% $4.38B -8.7x 4.6x
Akari Therapeutics Plc AKTX ██% $20M x 1.4x
Aldeyra Therapeutics, Inc. ALDX ██% $107M x 2.6x
Alkermes Plc. ALKS ██% $6.22B 40.7x 3.6x
Allarity Therapeutics, Inc. ALLR ██% $27M x 3.9x
Alumis Inc. ALMS ██% $2.79B x 4.9x
Alnylam Pharmaceuticals, Inc. ALNY ██% $39.12B 124.7x 49.6x
Altimmune, Inc. ALT ██% $570M x 2.0x
Alx Oncology Holdings Inc ALXO ██% $269M x 1.8x
Alzamend Neuro, Inc. ALZN ██% $4M x 2.0x
Amylyx Pharmaceuticals, Inc. AMLX ██% $1.52B x 5.6x
Amphastar Pharmaceuticals, Inc. AMPH ██% $840M 10.6x 1.1x
Amarin Corp Plc\Uk AMRN ██% $300M x 0.7x
Amneal Pharmaceuticals, Inc. AMRX ██% $4.07B 33.3x x
Anaptysbio, Inc ANAB ██% $1.68B x 131.6x
Anebulo Pharmaceuticals, Inc. ANEB ██% $19M x 2.4x
Ani Pharmaceuticals Inc ANIP ██% $1.70B 18.5x 3.0x
Anixa Biosciences Inc ANIX ██% $91M x 6.1x
Annexon, Inc. ANNX ██% $823M x 4.0x
Alto Neuroscience, Inc. ANRO ██% $738M x 3.0x
An2 Therapeutics, Inc. ANTX ██% $171M x 2.1x
Annovis Bio, Inc. ANVS ██% $88M x 28.0x
Apollomics Inc. APLM ██% $31M x x
Apellis Pharmaceuticals, Inc. APLS ██% $5.25B 39.4x 12.7x
Applied Therapeutics, Inc. APLT ██% $15M -0.7x 0.9x
Aprea Therapeutics, Inc. APRE ██% $11M x 0.3x
Apimeds Pharmaceuticals Us, Inc. APUS ██% $18M x 0.1x
Aptevo Therapeutics Inc. APVO ██% $6M x 0.5x
Aquestive Therapeutics, Inc. AQST ██% $507M x x
Arcturus Therapeutics Holdings Inc. ARCT ██% $205M x 1.1x
Ardelyx, Inc. ARDX ██% $1.54B x 10.4x
Arcutis Biotherapeutics, Inc. ARQT ██% $2.70B x 14.2x
Artelo Biosciences, Inc. ARTL ██% $3M x 0.5x
Arvinas, Inc. ARVN ██% $575M x 1.5x
Arrowhead Pharmaceuticals, Inc. ARWR ██% $11.06B x 18.0x
Aspire Biopharma Holdings, Inc. ASBP ██% $7M x 1.7x
Assembly Biosciences, Inc. ASMB ██% $457M x 2.3x
Ascendis Pharma A/S ASND ██% $14.85B x x
Assertio Holdings, Inc. ASRT ██% $151M x 2.0x
Atai Beckley N.V. ATAI ██% $1.58B x 9.9x
Alterity Therapeutics Ltd ATHE ██% $77M x x
Actinium Pharmaceuticals, Inc. ATNM ██% $36M x 15.8x
Atossa Therapeutics, Inc. ATOS ██% $43M x 1.4x
Avenue Therapeutics, Inc. ATXI ██% $760K x 0.6x
Astria Therapeutics, Inc. ATXS ██% $710M -4.7x 3.0x
Aurinia Pharmaceuticals Inc. AUPH ██% $2.03B 6.8x 3.6x
Arrivent Biopharma, Inc. AVBP ██% $1.27B x 3.9x
Avadel Pharmaceuticals Plc AVDL ██% $2.10B -10.2x 21.4x
Atea Pharmaceuticals, Inc. AVIR ██% $363M x 1.6x
Avalo Therapeutics, Inc. AVTX ██% $834M x 12.2x
Axim Biotechnologies, Inc. AXIM ██% $2M x x
Axsome Therapeutics, Inc. AXSM ██% $12.04B x 220.6x
Aytu Biopharma, Inc AYTU ██% $27M -0.3x 1.2x
Azitra, Inc. AZTR ██% $3M x 0.3x
Bridgebio Pharma, Inc. BBIO ██% $12.93B x x
Bridgebio Oncology Therapeutics, Inc. BBOT ██% $670M x 1.8x
Bicara Therapeutics Inc. BCAX ██% $1.44B x 2.8x
Briacell Therapeutics Corp. BCTX ██% $25M x 0.8x
Bicycle Therapeutics Plc BCYC ██% $319M x 0.6x
Bioadaptives, Inc. BDPT ██% $130K x x
Biodexa Pharmaceuticals Plc BDRX ██% $510K x x
Beone Medicines Ltd. BEIGF ██% $36.38B 530.6x 8.8x
Bullfrog Ai Holdings, Inc. BFRG ██% $13M x 2.7x
Biofrontera Inc. BFRI ██% $9M x 1.6x
Bio Green Med Solution, Inc. BGMS ██% $5M x 0.8x
Bausch Health Companies Inc. BHC ██% $2.02B x x
Bioharvest Sciences Inc. BHST ██% $89M x 3.5x
Biohaven Ltd. BHVN ██% $1.22B -4.6x 23.4x
Bioage Labs, Inc. BIOA ██% $719M x 1.9x
Bio Essence Corp BIOE ██% $13M 9.8x x
Biovie Inc. BIVI ██% $11M x 0.7x
Bioxytran, Inc BIXT ██% $3M x x
Biolinerx Ltd. BLRX ██% $14M x x
Belite Bio, Inc BLTE ██% $5.59B x 7.3x
Biomea Fusion, Inc. BMEA ██% $102M x 5.5x
Biomarin Pharmaceutical Inc BMRN ██% $10.18B 37.9x 1.6x
Bristol Myers Squibb Co BMY ██% $118.99B 16.4x 5.9x
Bristol Myers Squibb Co BMYMP ██% $1.73T 287.0x 93.4x
Benitec Biopharma Inc. BNTC ██% $393M x 2.2x
Boundless Bio, Inc. BOLD ██% $33M x 0.4x
Bolt Biotherapeutics, Inc. BOLT ██% $10M x 0.5x
Bio-Path Holdings, Inc. BPTH ██% $350K x x
Bioquest Corp BQST ██% $2M x x
Barinthus Biotherapeutics Plc. BRNS ██% $28M x 0.4x
Bespoke Extracts, Inc. BSPK ██% $2M x x
Bioxcel Therapeutics, Inc. BTAI ██% $38M x x
Beyondspring Inc. BYSI ██% $63M x x
Calcimedica, Inc. CALC ██% $12M x x
Camp4 Therapeutics Corp CAMP ██% $208M -0.1x 4.4x
Can-Fite Biopharma Ltd. CANF ██% $7M x 1.3x
Capricor Therapeutics, Inc. CAPR ██% $1.69B x 6.1x
Carisma Therapeutics Inc. CARM ██% $0.00M 0.0x x
Casi Pharmaceuticals, Inc. CASI ██% $5M -1.4x 2.5x
Perspective Therapeutics, Inc. CATX ██% $474M x 1.4x
Gyre Therapeutics, Inc. CBIO ██% $593M x 5.9x
Cdt Equity Inc. CDT ██% $4M x 1.0x
Cingulate Inc. CING ██% $56M x 3.0x
Cell Source, Inc. CLCS ██% $56M x x
Clene Inc. CLNN ██% $77M x x
Cellectar Biosciences, Inc. CLRB ██% $25M x 7.4x
Clearside Biomedical, Inc. CLSD ██% $4M -2.0x -0.7x
Clearside Biomedical, Inc. CLSDQ ██% $2M x x
Climb Bio, Inc. CLYM ██% $652M x 4.4x
Chemomab Therapeutics Ltd. CMMB ██% $15M x 1.2x
Clearmind Medicine Inc. CMND ██% $3M x x
Compass Pathways Plc CMPS ██% $1.65B x 5.1x
Cnbx Pharmaceuticals Inc. CNBX ██% $110K x x
Cns Pharmaceuticals, Inc. CNSP ██% $8M x 107.9x
Centessa Pharmaceuticals Plc CNTA ██% $6.16B x 12.6x
Connect Biopharma Holdings Ltd CNTB ██% $136M x 3.2x
Canton Strategic Holdings, Inc. CNTN ██% $236M x 0.5x
Context Therapeutics Inc. CNTX ██% $262M x 5.0x
Cocrystal Pharma, Inc. COCP ██% $16M x 3.8x
Cogent Biosciences, Inc. COGT ██% $5.80B x 9.5x
Collegium Pharmaceutical, Inc COLL ██% $1.09B 14.6x 3.5x
Corcept Therapeutics Inc CORT ██% $6.30B 133.2x 9.9x
Coya Therapeutics, Inc. COYA ██% $111M x 2.3x
China Pharma Holdings, Inc. CPHI ██% $31M x 0.8x
Cumberland Pharmaceuticals Inc CPIX ██% $86M x 4.0x
Cannapharmarx, Inc. CPMD ██% $3M x x
Catalyst Pharmaceuticals, Inc. CPRX ██% $3.83B 17.3x 3.8x
Corbus Pharmaceuticals Holdings, Inc. CRBP ██% $140M x 1.1x
Cormedix Inc. CRMD ██% $648M 3.6x 1.5x
Crinetics Pharmaceuticals, Inc. CRNX ██% $3.87B x 3.0x
Cervomed Inc. CRVO ██% $28M x 2.7x
Corvus Pharmaceuticals, Inc. CRVS ██% $1.08B x 4.5x
Cytomx Therapeutics, Inc. CTMX ██% $803M x 2.5x
Contineum Therapeutics, Inc. CTNM ██% $512M x 2.1x
Citius Oncology, Inc. CTOR ██% $80M x 2.3x
Hepion Pharmaceuticals, Inc. CTRVP ██% $20K x 0.0x
Ctt Pharmaceutical Holdings, Inc. CTTH ██% $5M x 6.7x
Citius Pharmaceuticals, Inc. CTXR ██% $19M x 0.3x
Cue Biopharma, Inc. CUE ██% $81M x 3.8x
Curanex Pharmaceuticals Inc CURX ██% $9M x 1.2x
Cadrenal Therapeutics, Inc. CVKD ██% $16M x 8.9x
Cv Sciences, Inc. CVSI ██% $6M x 3.7x
Cyclerion Therapeutics, Inc. CYCN ██% $14M x 2.0x
Cytodyn Inc. CYDY ██% $421M x x
Cypherpunk Technologies Inc. CYPH ██% $124M x 1.5x
Cryoport, Inc. CYRX ██% $701M 8.8x 1.4x
Cytokinetics Inc CYTK ██% $10.36B x x
Dare Bioscience, Inc. DARE ██% $34M x 46.4x
Day One Biopharmaceuticals, Inc. DAWN ██% $2.22B x 5.0x
Decoy Therapeutics Inc. DCOY ██% $4M x 1.2x
Journey Medical Corp DERM ██% $167M x 5.4x
Diamedica Therapeutics Inc. DMAC ██% $341M x 7.2x
Damora Therapeutics, Inc. DMRA ██% $1.59B x 3.1x
Dianthus Therapeutics, Inc. /De/ DNTH ██% $4.74B x 3.9x
Dermata Therapeutics, Inc. DRMA ██% $5M x 0.8x
Bright Minds Biosciences Inc. DRUG ██% $844M x x
Design Therapeutics, Inc. DSGN ██% $712M x 3.3x
Dynavax Technologies Corp DVAX ██% $1.82B 88.2x 3.4x
Dogwood Therapeutics, Inc. DWTX ██% $59M x 0.7x
Dyne Therapeutics, Inc. DYN ██% $3.00B x 3.5x
Emergent Biosolutions Inc. EBS ██% $473M x 0.9x
Edesa Biotech, Inc. EDSA ██% $86M x 8.5x
Eagle Pharmaceuticals, Inc. EGRX ██% $4M 0.4x 0.0x
Pmgc Holdings Inc. ELAB ██% $8M x 0.6x
Elanco Animal Health Inc ELAN ██% $11.40B x 1.8x
Eledon Pharmaceuticals, Inc. ELDN ██% $295M x 6.6x
Elite Pharmaceuticals Inc /Nv/ ELTP ██% $366M 13.4x 4.6x
Elicio Therapeutics, Inc. ELTX ██% $187M x x
Enliven Therapeutics, Inc. ELVN ██% $2.59B x 5.7x
Emmaus Life Sciences, Inc. EMMA ██% $700K x x
Enlivex Ltd. ENLV ██% $165M 0.1x 0.1x
Ensysce Biosciences, Inc. ENSC ██% $5M x x
Enanta Pharmaceuticals Inc ENTA ██% $388M x 3.3x
Gridai Technologies Corp. ENTO ██% $7M 0.0x 0.3x
Enveric Biosciences, Inc. ENVB ██% $8M x 1.6x
Evolus, Inc. EOLS ██% $412M x x
Essa Pharma Inc. EPIX ██% $9M -2.7x 0.1x
Eupraxia Pharmaceuticals Inc. EPRX ██% $492M x 6.0x
Equillium, Inc. EQ ██% $147M x 2.5x
Erasca, Inc. ERAS ██% $3.92B x 10.0x
Ernexa Therapeutics Inc. ERNA ██% $13M x 1.9x
Esperion Therapeutics, Inc. ESPR ██% $784M x x
89bio, Inc. ETNB ██% $2.20B -3.5x 4.2x
Eton Pharmaceuticals, Inc. ETON ██% $856M x 28.0x
Earth Science Tech, Inc. ETST ██% $49M 12.1x 8.6x
Evofem Biosciences, Inc. EVFM ██% $870K x x
Evommune, Inc. EVMN ██% $841M x 2.8x
Edgewise Therapeutics, Inc. EWTX ██% $3.61B x 7.3x
Fuss Brands Corp. FBDS ██% $2M x 0.0x
Fortress Biotech, Inc. FBIO ██% $89M 0.7x 0.6x
Fortress Biotech, Inc. FBIOP ██% $394M 98.8x 7.1x
Fibrobiologics, Inc. FBLG ██% $6M x 2.1x
Forte Biosciences, Inc. FBRX ██% $449M x 10.7x
Fibrogen Inc FGEN ██% $35M 0.2x -3.6x
Foghorn Therapeutics Inc. FHTX ██% $257M x x
Filana Therapeutics, Inc. FLNA ██% $68M x 1.0x
Amicus Therapeutics, Inc. FOLD ██% $4.50B x 16.4x
Fulcrum Therapeutics, Inc. FULC ██% $451M x 1.4x
Galectin Therapeutics Inc GALT ██% $184M x x
Gain Therapeutics, Inc. GANX ██% $77M x 5.5x
Generation Bio Co. GBIO ██% $36M -0.6x 0.7x
Greater Cannabis Company, Inc. GCAN ██% $140K x x
Cytomed Therapeutics Ltd GDTC ██% $14M x x
Geron Corp GERN ██% $835M x 3.7x
Gh Research Plc GHRS ██% $1.44B x x
Galmed Pharmaceuticals Ltd. GLMD ██% $4M x 0.3x
Lakefront Biotherapeutics Nv GLPG ██% $1.85B x x
Greenwich Lifesciences, Inc. GLSI ██% $378M x 172.9x
Galecto, Inc. GLTO ██% $1.59B -2.5x 198.2x
Genelux Corp GNLX ██% $135M x 5.9x
Genprex, Inc. GNPX ██% $8M x 0.5x
Gossamer Bio, Inc. GOSS ██% $52M x x
Geovax Labs, Inc. GOVX ██% $12M x 24.6x
Structure Therapeutics Inc. GPCR ██% $2.84B x 2.0x
Grace Therapeutics, Inc. GRCE ██% $37M x 0.6x
Gridai Technologies Corp. GRDX ██% $29M x 1.3x
Gri Bio, Inc. GRI ██% $4M x 0.4x
Galera Therapeutics, Inc. GRTX ██% $20M 0.1x 27.9x
Gsk Plc GSK ██% $103.34B x x
Gt Biopharma, Inc. GTBP ██% $14M x 1.9x
Gyre Therapeutics, Inc. GYRE ██% $543M x 5.4x
Hutchmed (China) Ltd HCM ██% $2.02B 2.2x 1.6x
Hcw Biologics Inc. HCWB ██% $18M x 3.1x
Cybin Inc. HELP ██% $221M x x
Hepion Pharmaceuticals, Inc. HEPA ██% $2M x 1.2x
Vyome Holdings, Inc HIND ██% $16M x 2.4x
Hutchmed (China) Ltd HMDCF ██% $2.64B x 2.1x
Hookipa Pharma Inc. HOOK ██% $15M x 0.4x
Hoth Therapeutics, Inc. HOTH ██% $14M x 3.3x
Werewolf Therapeutics, Inc. HOWL ██% $22M x 1.8x
Harmony Biosciences Holdings, Inc. HRMY ██% $1.74B 12.0x 1.9x
Heron Therapeutics, Inc. /De/ HRTX ██% $167M x 18.3x
Hst Global, Inc. HSTC ██% $99M x 79.9x
Tuhura Biosciences, Inc./Nv HURA ██% $156M x 6.7x
Mindwalk Holdings Corp. HYFT ██% $76M x x
Hyperion Defi, Inc. HYPD ██% $56M x 1.0x
Ibio, Inc. IBIO ██% $90M x 1.2x
Impact Biomedical Inc. IBO ██% $55M x 4.8x
Ideaya Biosciences, Inc. IDYA ██% $2.58B x 2.8x
Inflarx N.V. IFRX ██% $404M x x
Igc Pharma, Inc. IGC ██% $29M x 4.7x
Immutep Ltd IMMP ██% $66M x x
Immix Biopharma, Inc. IMMX ██% $629M x 7.5x
Immunome Inc. IMNM ██% $2.48B x 4.2x
Imunon, Inc. IMNN ██% $9M x 2.6x
Immuron Ltd IMRN ██% $8M x x
Immuneering Corp IMRX ██% $341M x 1.7x
Eom Pharmaceutical Holdings, Inc. IMUC ██% $6M x 1.8x
Immunic, Inc. IMUX ██% $177M x 1.2x
Integrated Biopharma Inc INBP ██% $6M x 0.3x
Indaptus Therapeutics, Inc. INDP ██% $126M x 100.7x
Indivior Pharmaceuticals, Inc. INDV ██% $4.69B 18.6x x
Inmed Pharmaceuticals Inc. INM ██% $6M x 0.8x
Inovio Pharmaceuticals, Inc. INO ██% $104M x 17.1x
Insmed Inc INSM ██% $23.57B x 33.4x
Inhibitor Therapeutics, Inc. INTI ██% $13M x x
Innoviva, Inc. INVA ██% $1.67B 3.3x 1.3x
Io Biotech, Inc. IOBT ██% $540K x 0.6x
Io Biotech, Inc. IOBTQ ██% $210K x 0.2x
Ionis Pharmaceuticals Inc IONS ██% $12.62B x 25.7x
Opus Genetics, Inc. IRD ██% $333M x x
Disc Medicine, Inc. IRON ██% $2.60B x 3.8x
Ironwood Pharmaceuticals Inc IRWD ██% $642M 6.3x x
International Stem Cell Corp ISCO ██% $1M x x
Iterum Therapeutics Plc ITRM ██% $1M x x
Inventiva S.A. IVA ██% $1.08B x x
Incannex Healthcare Inc. IXHL ██% $40M x 0.5x
Jaguar Health, Inc. JAGX ██% $2M x x
Janux Therapeutics, Inc. JANX ██% $876M x 0.9x
Jazz Pharmaceuticals Plc JAZZ ██% $14.70B 498.3x 3.2x
Jade Biosciences, Inc. JBIO ██% $1.07B x 3.6x
Johnson & Johnson JNJ ██% $554.43B 26.4x 6.8x
Jupiter Neurosciences, Inc. JUNS ██% $10M x x
Kala Bio, Inc. KALA ██% $40M x 3.8x
Kalvista Pharmaceuticals, Inc. KALV ██% $1.37B x x
Kairos Pharma, Ltd. KAPA ██% $11M x 2.1x
Kaya Holdings, Inc. KAYS ██% $6M x x
Kamada Ltd KMDA ██% $459M x x
Kiniksa Pharmaceuticals International, Plc KNSA ██% $4.04B 55.4x 6.7x
Kiora Pharmaceuticals Inc KPRX ██% $7M -2.4x 0.3x
Karyopharm Therapeutics Inc. KPTI ██% $202M x x
Keros Therapeutics, Inc. KROS ██% $222M x 0.8x
Korro Bio, Inc. KRRO ██% $178M x 1.5x
Pasithea Therapeutics Corp. KTTA ██% $23M x 0.4x
Kura Oncology, Inc. KURA ██% $924M x 8.6x
Kyntra Bio, Inc. KYNB ██% $28M 0.2x x
Kezar Life Sciences, Inc. KZR ██% $54M x 0.8x
Lb Pharmaceuticals Inc LBRX ██% $812M x 2.2x
Legend Biotech Corp LEGN ██% $5.48B x x
Lexaria Bioscience Corp. LEXX ██% $17M x 2.5x
Lifecore Biomedical, Inc. \De\ LFCR ██% $180M x x
Lifevantage Corp LFVN ██% $87M 11.1x 2.6x
Ligand Pharmaceuticals Inc LGND ██% $4.71B 30.7x 4.7x
Longeveron Inc. LGVN ██% $26M x 1.6x
Lianbio LIANY ██% $12M x 0.1x
Lftd Partners Inc. LIFD ██% $3M x 0.3x
Lipella Pharmaceuticals Inc. LIPO ██% $460K x 0.3x
Lite Strategy, Inc. LITS ██% $37M x 0.7x
Lixte Biotechnology Holdings, Inc. LIXT ██% $70M x 8.8x
Lixte Biotechnology Holdings, Inc. LIXTW ██% $130K x 0.0x
Lakefront Biotherapeutics Nv LKFT ██% $1.82B x x
Eli Lilly & Co LLY ██% $952.41B 37.7x 30.5x
Lunai Bioworks Inc. LNAI ██% $10M x x
Lipocine Inc. LPCN ██% $17M x 0.7x
Cypherpunk Technologies Inc. LPTX ██% $94M -1.1x 35.1x
Liquidia Corp LQDA ██% $5.31B 237.9x 48.9x
Larimar Therapeutics, Inc. LRMR ██% $360M x 2.3x
Lisata Therapeutics, Inc. LSTA ██% $29M x 2.7x
Lantern Pharma Inc. LTRN ██% $43M x 12.5x
Lava Therapeutics Nv LVTX ██% $46M x 3.6x
Lexicon Pharmaceuticals, Inc. LXRX ██% $877M x 4.3x
Lyell Immunopharma, Inc. LYEL ██% $382M x 1.4x
Maia Biotechnology, Inc. MAIA ██% $81M x 2.9x
Mustang Bio, Inc. MBIO ██% $5M x 0.6x
Moleculin Biotech, Inc. MBRX ██% $13M x 0.9x
Mbx Biosciences, Inc. MBX ██% $1.51B x 3.5x
Seres Therapeutics, Inc. MCRB ██% $73M x 2.8x
Medicus Pharma Ltd. MDCX ██% $17M x 12.5x
Medicus Pharma Ltd. MDCXW ██% $52M x x
Madrigal Pharmaceuticals, Inc. MDGL ██% $12.08B x 22.2x
Chrome Holding Co. MEHCQ ██% $96M x x
Macrogenics Inc MGNX ██% $284M x 13.4x
Mira Pharmaceuticals, Inc. MIRA ██% $41M x 4.4x
Mirum Pharmaceuticals, Inc. MIRM ██% $6.03B x 24.9x
Milestone Pharmaceuticals Inc. MIST ██% $165M x 4.6x
Moonlake Immunotherapeutics MLTX ██% $1.30B x 5.1x
Mineralys Therapeutics, Inc. MLYS ██% $2.47B x 3.9x
Mannkind Corp MNKD ██% $1.09B x x
Medicinova Inc MNOV ██% $67M x 1.7x
Monopar Therapeutics MNPR ██% $420M x 3.1x
Maplight Therapeutics, Inc. MPLT ██% $1.33B x 3.3x
Mereo Biopharma Group Plc MREO ██% $53M x 1.6x
Merck & Co., Inc. MRK ██% $295.95B 33.1x 6.5x
Marker Therapeutics, Inc. MRKR ██% $24M x 1.8x
Mersana Therapeutics, Inc. MRSN ██% $145M -3.4x -1.4x
Merus N.V. MRUS ██% $6.83B -13.5x 8.8x
Maravai Lifesciences Holdings, Inc. MRVI ██% $1.62B x 7.6x
Matinas Biopharma Holdings, Inc. MTNB ██% $5M x 1.5x
Metsera, Inc. MTSR ██% $7.41B x 22.0x
Metavia Inc. MTVA ██% $15M x 1.7x
Mural Oncology Plc MURA ██% $35M x 0.6x
Mainz Biomed N.V. MYNZ ██% $7M x x
Newamsterdam Pharma Co N.V. NAMS ██% $4.21B x 6.3x
Newamsterdam Pharma Co N.V. NAMSW ██% $2.59B x 3.6x
Natures Sunshine Products Inc NATR ██% $384M 19.3x 2.3x
Novabridge Biosciences NBP ██% $215M x 0.8x
Nanobiotix S.A. NBTX ██% $1.49B x x
Stablecoin Development Corp NBY ██% $37M x x
Newcelx Ltd. NCEL ██% $17M x 31.3x
Nucana Plc NCNA ██% $8M x x
Minerva Neurosciences, Inc. NERV ██% $229M x x
Neuphoria Therapeutics Inc. NEUP ██% $29M x 1.0x
Neurogene Inc. NGNE ██% $423M x 1.8x
Nika Pharmaceuticals, Inc NIKA ██% $535M x x
Nektar Therapeutics NKTR ██% $2.22B x 3.8x
Nkarta, Inc. NKTX ██% $227M x 0.8x
Newcelx Ltd. NLSP ██% $54M x 98.9x
Newcelx Ltd. NLSPW ██% $120K x 0.2x
Nanoviricides, Inc. NNVC ██% $33M x 3.6x
Nurix Therapeutics, Inc. NRIX ██% $1.80B x 3.7x
Neurosense Therapeutics Ltd. NRSN ██% $31M x x
Nrx Pharmaceuticals, Inc. NRXP ██% $144M x x
Neonc Technologies Holdings, Inc. NTHI ██% $128M x x
Nuvation Bio Inc. NUVB ██% $1.63B x 5.1x
Nuvalent, Inc. NUVL ██% $8.26B x 7.0x
Nuvectis Pharma, Inc. NVCT ██% $268M x 18.8x
Novartis Ag NVS ██% $287.75B x x
Northwest Biotherapeutics Inc NWBO ██% $337M x x
Nexien Biopharma, Inc. NXEN ██% $10K x x
Nextcure, Inc. NXTC ██% $25M x 1.0x
Nexentis Technologies Inc. NXTS ██% $4M x 0.3x
Ocean Biomedical, Inc. OCEA ██% $190K -0.3x 0.1x
Ocular Therapeutix, Inc OCUL ██% $1.81B x 3.1x
Oragenics Inc OGEN ██% $3M x 0.4x
Organigram Global Inc. OGI ██% $156M x x
Organon & Co. OGN ██% $3.52B 14.3x 3.9x
Onkure Therapeutics, Inc. OKUR ██% $166M x 0.9x
Olema Pharmaceuticals, Inc. OLMA ██% $1.18B x 2.5x
Omeros Corp OMER ██% $839M 9.7x x
Beone Medicines Ltd. ONC ██% $31.38B 61.2x 6.6x
Onconetix, Inc. ONCO ██% $1M x 0.1x
Oncolytics Biotech Inc ONCY ██% $94M x x
Opko Health, Inc. OPK ██% $979M x 0.8x
Organogenesis Holdings Inc. ORGO ██% $342M 125.9x 1.4x
Orgenesis Inc. ORGS ██% $3M x x
Oric Pharmaceuticals, Inc. ORIC ██% $884M x 2.1x
Oruka Therapeutics, Inc. ORKA ██% $3.56B x 7.3x
Oramed Pharmaceuticals Inc. ORMP ██% $165M 1.5x 0.7x
Os Therapies Inc OSTX ██% $78M x x
Oncotelic Therapeutics, Inc. OTLC ██% $27M x 0.1x
Ovid Therapeutics Inc. OVID ██% $457M x 2.3x
One World Products, Inc. OWPC ██% $670K x x
Phibro Animal Health Corp PAHC ██% $1.37B 14.3x 3.8x
Prestige Consumer Healthcare Inc. PBH ██% $2.33B 12.2x 1.2x
Psyence Biomedical Ltd. PBM ██% $10M x x
Puma Biotechnology, Inc. PBYI ██% $370M 15.2x 2.9x
Pacira Biosciences, Inc. PCRX ██% $958M 186.4x 1.5x
Processa Pharmaceuticals, Inc. PCSA ██% $7M x 2.6x
Procyon Corp PCYN ██% $2M x 0.7x
Pds Biotechnology Corp PDSB ██% $61M x 15.8x
Pepgen Inc. PEPG ██% $106M x 0.8x
Pfizer Inc PFE ██% $147.11B 19.6x 1.6x
Precigen, Inc. PGEN ██% $1.51B x 74.6x
Phathom Pharmaceuticals, Inc. PHAT ██% $882M x x
Phio Pharmaceuticals Corp. PHIO ██% $13M x 0.8x
Pharvaris N.V. PHVS ██% $2.09B x x
Protokinetix, Inc. PKTX ██% $2M x 9.0x
Plandai Biotechnology, Inc. PLPL ██% $4M x 14.6x
Pliant Therapeutics, Inc. PLRX ██% $77M x 0.5x
Polomar Health Services, Inc. PMHS ██% $4M x 0.5x
Promis Neurosciences Inc. PMN ██% $93M x 1.5x
Pmv Pharmaceuticals, Inc. PMVP ██% $66M x 0.8x
Purple Biotech Ltd. PPBT ██% $3M x x
Propanc Biopharma, Inc. PPCB ██% $4M x 0.4x
Praxis Precision Medicines, Inc. PRAX ██% $9.77B x 6.9x
Prf Technologies Ltd. PRFX ██% $1M x 0.1x
Perrigo Co Plc PRGO ██% $1.49B x 0.6x
Prelude Therapeutics Inc PRLD ██% $338M x 5.6x
Prophase Labs, Inc. PRPH ██% $430K x 0.1x
Proqr Therapeutics N.V. PRQR ██% $165M x x
Prothena Corp Public Ltd Co PRTA ██% $534M x 1.7x
Ptc Therapeutics, Inc. PTCT ██% $5.61B x x
Protagonist Therapeutics, Inc PTGX ██% $6.42B x 9.8x
Protagenic Therapeutics, Inc.\New PTIX ██% $1M x x
Palatin Technologies Inc PTN ██% $26M x 2.4x
Palatin Technologies Inc PTNT ██% $17M x 43.1x
Petros Pharmaceuticals, Inc. PTPI ██% $250K 0.1x 0.1x
Pulmatrix, Inc. PULM ██% $5M x 1.4x
Provectus Biopharmaceuticals, Inc. PVCT ██% $27M x x
Palvella Therapeutics, Inc. PVLA ██% $1.68B x 7.3x
Pyxis Oncology, Inc. PYXS ██% $102M x 3.3x
Aixcrypto Holdings, Inc. QLGN ██% $8M -1.3x 0.2x
Quoin Pharmaceuticals, Ltd. QNRX ██% $10M x 1.1x
Quantum Biopharma Ltd. QNTM ██% $45M x x
Q32 Bio Inc. QTTB ██% $120M 3.6x 2.6x
Quantum Cyber N.V. QUCY ██% $51M x 11.1x
Uniqure N.V. QURE ██% $1.59B x 10.6x
Radiopharm Theranostics Ltd RADX ██% $36M x x
Rani Therapeutics Holdings, Inc. RANI ██% $118M x 4.1x
Rapport Therapeutics, Inc. RAPP ██% $1.90B x 4.0x
Rapt Therapeutics, Inc. RAPT ██% $1.56B -0.4x 10.3x
Ultragenyx Pharmaceutical Inc. RARE ██% $2.27B x x
Rocket Pharmaceuticals, Inc. RCKT ██% $327M x 1.4x
Arcus Biosciences, Inc. RCUS ██% $3.03B x 5.8x
Dr Reddys Laboratories Ltd RDY ██% $11.48B x x
Regeneron Pharmaceuticals, Inc. REGN ██% $66.00B 14.9x 2.1x
Revelation Biosciences, Inc. REVB ██% $4M x 0.3x
Rafael Holdings, Inc. RFL ██% $68M x 0.9x
Regen Biopharma Inc RGBP ██% $150K x x
Regen Biopharma Inc RGBPP ██% $470K x x
Rigel Pharmaceuticals Inc RIGL ██% $537M 1.5x 1.3x
Relmada Therapeutics, Inc. RLMD ██% $752M x 3.4x
Rallybio Corp RLYB ██% $78M x 1.6x
Retrieve Medical Holdings, Inc. RMHI ██% $30M x x
Rockwell Medical, Inc. RMTI ██% $30M x 0.8x
Avidity Biosciences, Inc. RNA ██% $206M -12.2x 0.1x
Cartesian Therapeutics, Inc. RNAC ██% $184M x x
Transcode Therapeutics, Inc. RNAZ ██% $5M x 4.0x
Rein Therapeutics, Inc. RNTX ██% $92M x 7.9x
Renovorx, Inc. RNXT ██% $41M x 3.7x
Roivant Sciences Ltd. ROIV ██% $21.37B x 4.7x
Royalty Pharma Plc RPRX ██% $31.01B 37.5x 4.5x
Repare Therapeutics Inc. RPTX ██% $114M -2.1x 1.0x
Rest Ez Inc. RTEZ ██% $1.93B x x
Rapid Therapeutic Science Laboratories, Inc. RTSL ██% $110K 1.9x 0.3x
Reviva Pharmaceuticals Holdings, Inc. RVPH ██% $5M x 0.3x
Rhythm Pharmaceuticals, Inc. RYTM ██% $6.15B x 50.0x
Rezolute, Inc. RZLT ██% $318M x 2.7x
Filana Therapeutics, Inc. SAVA ██% $101M -1.9x 1.2x
Sunshine Biopharma Inc. SBFM ██% $7M x 0.3x
Scienture Holdings, Inc. SCNX ██% $16M x 0.2x
Scpharmaceuticals Inc. SCPH ██% $302M -2.0x -50.9x
Scorpius Holdings, Inc. SCPX ██% $610K x x
Scynexis Inc SCYX ██% $54M x 1.3x
Stablecoin Development Corp SDEV ██% $35M 0.1x 0.3x
Schrodinger, Inc. SDGR ██% $973M x 3.1x
Septerna, Inc. SEPN ██% $1.38B x 3.6x
Serina Therapeutics, Inc. SER ██% $29M x 1.6x
Sagimet Biosciences Inc. SGMT ██% $446M x 4.4x
Shuttle Pharmaceuticals Holdings, Inc. SHPH ██% $3M x 1.0x
Siga Technologies Inc SIGA ██% $335M 16.6x 2.2x
Silo Pharma, Inc. SILO ██% $7M x 1.2x
Sionna Therapeutics, Inc. SION ██% $1.93B x 6.7x
Skinvisible, Inc. SKVI ██% $1M x x
Skye Bioscience, Inc. SKYE ██% $29M x 3.2x
Sol-Gel Technologies Ltd. SLGL ██% $242M x 10.6x
Silence Therapeutics Plc SLN ██% $314M x 6.4x
Silence Therapeutics Plc SLNCF ██% $213M x 2.9x
Soleno Therapeutics Inc SLNO ██% $2.74B 28.6x 5.5x
Salarius Pharmaceuticals, Inc. SLRX ██% $2M -0.5x 0.4x
Sellas Life Sciences Group, Inc. SLS ██% $1.47B x 13.7x
Summit Therapeutics Inc. SMMT ██% $13.19B x 24.2x
Semnur Pharmaceuticals, Inc. SMNR ██% $1.15B x x
Syndax Pharmaceuticals Inc SNDX ██% $1.77B x 42.6x
Soligenix, Inc. SNGX ██% $8M x 2.5x
Sibannac, Inc. SNNC ██% $2M x x
Sensei Biotherapeutics, Inc. SNSE ██% $22M x x
Sanofi SNY ██% $107.02B x x
Sonnet Biotherapeutics Holdings, Inc. SONN ██% $4M -1.6x 29.5x
Spruce Biosciences, Inc. SPRB ██% $143M x 4.1x
Scisparc Ltd. SPRC ██% $3M x x
Spero Therapeutics, Inc. SPRO ██% $166M 10.9x 3.1x
Ars Pharmaceuticals, Inc. SPRY ██% $811M x 13.2x
Sarepta Therapeutics, Inc. SRPT ██% $1.76B 27.1x 1.2x
Stoke Therapeutics, Inc. STOK ██% $1.93B x 4.9x
Shattuck Labs, Inc. STTK ██% $462M x 4.8x
Supernus Pharmaceuticals, Inc. SUPN ██% $2.76B x 2.6x
Savara Inc SVRA ██% $1.05B x 6.0x
60 Degrees Pharmaceuticals, Inc. SXTP ██% $4M x 0.8x
Synlogic, Inc. SYBX ██% $8M x 0.6x
Spyre Therapeutics, Inc. SYRE ██% $5.81B x 8.7x
Syros Pharmaceuticals, Inc. SYRS ██% $20K -0.1x -0.4x
Takeda Pharmaceutical Co Ltd TAK ██% $51.16B x x
Theravance Biopharma, Inc. TBPH ██% $844M 7.4x 2.9x
Alaunos Therapeutics, Inc. TCRT ██% $6M x 4.6x
Telomir Pharmaceuticals, Inc. TELO ██% $87M x 17.6x
Tenax Therapeutics, Inc. TENX ██% $316M x 2.8x
Terns Pharmaceuticals, Inc. TERN ██% $6.12B x 6.1x
Teva Pharmaceutical Industries Ltd TEVA ██% $40.72B 26.0x 5.0x
Teva Pharmaceutical Industries Ltd TEVJF ██% $38.09B 53.4x 5.3x
Tg Therapeutics, Inc. TGTX ██% $6.15B 13.3x 10.5x
Canton Strategic Holdings, Inc. THAR ██% $186M x 30.2x
Talphera, Inc. TLPH ██% $41M x 2.2x
Telix Pharmaceuticals Ltd TLX ██% $3.29B x x
Tango Therapeutics, Inc. TNGX ██% $2.89B x 7.4x
Tonix Pharmaceuticals Holding Corp. TNXP ██% $197M x 0.9x
Theriva Biologics, Inc. TOVX ██% $13M x 0.9x
Tempest Therapeutics, Inc. TPST ██% $26M x 31.0x
Traws Pharma, Inc. TRAW ██% $17M -0.6x 1.5x
Entrada Therapeutics, Inc. TRDA ██% $262M x 1.0x
Trevi Therapeutics, Inc. TRVI ██% $1.86B x 10.8x
Trevena Inc TRVN ██% $260K -1.3x 1.5x
Turn Therapeutics Inc. TTRX ██% $157M x 25.6x
Tvardi Therapeutics, Inc. TVRD ██% $33M x 2.3x
Travere Therapeutics, Inc. TVTX ██% $4.16B x 42.1x
Therapeuticsmd, Inc. TXMD ██% $25M 137.1x 0.9x
Tyra Biosciences, Inc. TYRA ██% $2.03B x 5.3x
Unicycive Therapeutics, Inc. UNCY ██% $180M x 4.8x
Upstream Bio, Inc. UPB ██% $465M x 1.5x
Urogen Pharma Ltd. URGN ██% $1.47B x x
United Therapeutics Corp UTHR ██% $24.32B 18.9x 4.1x
Vaccinex, Inc. VCNX ██% $3M x x
Vera Therapeutics, Inc. VERA ██% $2.51B x 5.0x
Veru Inc. VERU ██% $39M -0.8x 2.1x
Sb Technology Holdings, Inc. VGLS ██% $710K x x
Sb Technology Holdings, Inc. VGLSD ██% $520K x x
Vicapsys Life Sciences, Inc. VICP ██% $47M x x
Vincerx Pharma, Inc. VINC ██% $70K -0.2x 0.0x
Viracta Therapeutics, Inc. VIRX ██% $390K -0.2x 0.2x
Viking Therapeutics, Inc. VKTX ██% $3.68B x 7.3x
Vanda Pharmaceuticals Inc. VNDA ██% $387M x 1.4x
Verrica Pharmaceuticals Inc. VRCA ██% $108M x 6.7x
Viridian Therapeutics, Inc.\De VRDN ██% $1.77B x 2.8x
Vireo Growth Inc. VREOF ██% $348M x 1.4x
Verona Pharma Plc VRNA ██% $73.55B -185.1x 264.3x
Virpax Pharmaceuticals, Inc. VRPX ██% $160K 0.0x -19.5x
Vertex Pharmaceuticals Inc / Ma VRTX ██% $112.18B 25.9x 5.8x
Verastem, Inc. VSTM ██% $376M x 4.6x
Vistagen Therapeutics, Inc. VTGN ██% $27M x 0.5x
Viatris Inc VTRS ██% $18.82B x 1.3x
Vtv Therapeutics Inc. VTVT ██% $0.00M -3.3x -7.5x
Ventyx Biosciences, Inc. VTYX ██% $999M -1.0x 5.2x
Vyne Therapeutics Inc. VYNE ██% $22M x 0.9x
Whitehawk Therapeutics, Inc. WHWK ██% $227M x 2.0x
Wave Life Sciences Ltd. WVE ██% $1.24B x 2.4x
Xenetic Biosciences, Inc. XBIO ██% $7M x 1.0x
Xbiotech Inc. XBIT ██% $74M x 0.6x
Exicure, Inc. XCUR ██% $18M x 4.5x
Xenon Pharmaceuticals Inc. XENE ██% $5.19B x 3.9x
Xeris Biopharma Holdings, Inc. XERS ██% $1.08B 90.1x 83.2x
Xilio Therapeutics, Inc. XLO ██% $49M x 0.7x
Xencor Inc XNCR ██% $882M x 1.7x
Xoma Royalty Corp XOMA ██% $497M 14.7x 5.4x
Xoma Royalty Corp XOMAO ██% $312M 14.4x 3.6x
Xoma Royalty Corp XOMAP ██% $326M 15.1x 3.7x
Xtl Biopharmaceuticals Ltd XTLB ██% $6M x x
Zenas Biopharma, Inc. ZBIO ██% $1.16B x 3.4x
Zai Lab Ltd ZLAB ██% $2.08B x 3.1x
Zentalis Pharmaceuticals, Inc. ZNTL ██% $285M x 1.6x
Zomedica Corp. ZOMDF ██% $132M x 1.1x
Zoetis Inc. ZTS ██% $33.55B 12.7x 10.4x
Zevra Therapeutics, Inc. ZVRA ██% $643M 5.2x 3.1x
Zyversa Therapeutics, Inc. ZVSA ██% $2M x x
Zymeworks Inc. ZYME ██% $1.75B -8.3x 6.5x
Reveal all forecasts See exact % predictions for all competitors
Sign up free

Frequently Asked Questions - Clene Inc. Stock Forecast

How accurate are Clene Inc. stock predictions?

Our AI model shows a 21% Spearman correlation coefficient for CLNN predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Clene Inc. stock price forecasts?

Our analysis considers Clene Inc.'s financial metrics, Life Sciences sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Clene Inc. a good investment in 2025?

Based on our AI analysis, Clene Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Clene Inc. forecasts updated?

Clene Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want a simpler view of Clene Inc.?

View simplified analysis on AI Stock Finder →

My Portfolio

Investment Dashboard

Loading your portfolio...